Victoria Grasso, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2450 S Telshor Blvd, Las Cruces, NM 88011 Phone: 575-532-4419 |
John Wuthrich, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4311 E Lohman Ave, Las Cruces, NM 88011 Phone: 575-556-7786 |
News Archive
Biodel Inc. today announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and BIOD-125 - two proprietary ultra-rapid-acting formulations of recombinant human insulin.
Amgen today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion to extend the marketing authorization for Vectibix (panitumumab) to include combination with FOLFIRI (an irinotecan-based chemotherapy) as first-line treatment in adult patients with wild-type RAS metastatic colorectal cancer (mCRC).
After more than 100 years following its pathologic description, the cause of Alzheimer's disease (AD) remains unknown. To test the validity of present and future proposals related to the probable cause of AD, three postulates, or necessary conditions, are recommended by Jack de la Torre, MD, PhD, Adjunct Professor of Psychology at the University of Texas, Austin, in an article published in the Journal of Alzheimer's Disease.
A team of investigators from Cedars-Sinai and UCLA is using a new blood-analysis technique and tiny experimental device to help physicians predict which cancers are likely to spread by identifying and characterizing tumor cells circulating through the blood.
› Verified 9 days ago